These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 7113706

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Complement-dependent in vitro cytotoxicity against autologous invasive bladder tumor cells in humans. Evaluation of the possible role of naturally-occurring antibodies in complement-dependent cytotoxicity.
    Jacobsen F.
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):297-302. PubMed ID: 7315361
    [Abstract] [Full Text] [Related]

  • 3. Cellular and humoral in vitro cytotoxicity against autologous bladder tumor cells in humans. Differences in autologous cytotoxicity against non-invasive and invasive transitional-cell tumors of the urinary bladder.
    Jacobsen F.
    Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):235-9. PubMed ID: 7315359
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte cytotoxicity against autologous bladder tumor cells in humans, investigated by use of a chromium-51 release assay.
    Jacobsen F.
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):175-80. PubMed ID: 7315355
    [Abstract] [Full Text] [Related]

  • 5. Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer.
    Mizutani Y, Okada Y, Yoshida O, Bonavida B.
    Cancer Biother Radiopharm; 1996 Dec; 11(6):385-91. PubMed ID: 10851499
    [Abstract] [Full Text] [Related]

  • 6. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
    Mizutani Y, Yoshida O.
    J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
    [Abstract] [Full Text] [Related]

  • 7. Cytolysis of neuraminidase-treated autochthonous lymphoid cells by autologous serum.
    Ray PK, Sundaram K.
    Clin Exp Immunol; 1975 Mar; 19(3):529-32. PubMed ID: 1204249
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [Abstract] [Full Text] [Related]

  • 9. In vitro cytotoxicity of lymphocyte subpopulations against autologous human bladder tumor cells.
    Jacobsen F.
    Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):241-6. PubMed ID: 6976062
    [Abstract] [Full Text] [Related]

  • 10. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
    Lambre CR, Thibon M, Le Maho S, Di Bella G.
    Immunology; 1983 Jun; 49(2):311-9. PubMed ID: 6852870
    [Abstract] [Full Text] [Related]

  • 11. Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer.
    Mizutani Y, Nio Y, Fukumoto M, Yoshida O.
    Cancer; 1992 Jan 15; 69(2):537-45. PubMed ID: 1728384
    [Abstract] [Full Text] [Related]

  • 12. Antibodies against tumor cell glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicity.
    Ragupathi G, Liu NX, Musselli C, Powell S, Lloyd K, Livingston PO.
    J Immunol; 2005 May 01; 174(9):5706-12. PubMed ID: 15843572
    [Abstract] [Full Text] [Related]

  • 13. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes.
    Mizutani Y, Nio Y, Yoshida O.
    Cancer; 1992 Jun 15; 69(12):2999-3007. PubMed ID: 1591693
    [Abstract] [Full Text] [Related]

  • 14. Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y, Nio Y, Yoshida O.
    J Urol; 1992 Feb 15; 147(2):505-10. PubMed ID: 1732632
    [Abstract] [Full Text] [Related]

  • 15. Specific lysis of human colon tumor cells by antibodies to CEA and isoantigen A: dependence on rabbit serum or neuraminidase.
    Tompkins WA, Seth PB, Yip DM, Palmer JL, Gee SR, Rawls WE.
    J Immunol; 1976 Nov 15; 117(5 Pt.2):1943-8. PubMed ID: 792333
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.
    Cook EM, Lindorfer MA, van der Horst H, Oostindie S, Beurskens FJ, Schuurman J, Zent CS, Burack R, Parren PW, Taylor RP.
    J Immunol; 2016 Sep 01; 197(5):1762-75. PubMed ID: 27474078
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
    Troye M, Vilien M, Pape GR, Perlmann P.
    Int J Cancer; 1980 Jan 15; 25(1):33-43. PubMed ID: 7399743
    [Abstract] [Full Text] [Related]

  • 20. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 15; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.